Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours
August 20, 2018 02:00 ET
|
Immunocore Limited
PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Study of IMCnyeso in NSCLC, Bladder Cancer, Melanoma and Synovial Sarcoma is the first in GSK...